Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

AKT inhibitors in research and application

Dr Brian Schwartz - ArQule, Burlington, USA
AKT inhibitors in research and application ( Dr Brian Schwartz - ArQule, Burlington, USA )
25 Apr 2018

Increasing diversity through the NCI SBIR development centre

Dr Christie Canaria - National Cancer Institute, Rockville, USA
Increasing diversity through the NCI SBIR development centre ( Dr Christie Canaria - National Cancer Institute, Rockville, USA )
25 Apr 2018

Clinical development and economic prospects of CAR T cell immunotherapies

Dr Bob Velamehr - Fate Therapeutics, La Jolla, USA
Clinical development and economic prospects of CAR T cell immunotherapies ( Dr Bob Velamehr - Fate Therapeutics, La Jolla, USA )
25 Apr 2018

Response and safety profile of neoadjuvant nivolumab for resectable lung cancer

Dr Drew Pardoll - Johns Hopkins Medicine, Baltimore, USA
Response and safety profile of neoadjuvant nivolumab for resectable lung cancer ( Dr Drew Pardoll - Johns Hopkins Medicine, Baltimore, USA )
25 Apr 2018

Doubled survival in metastatic lung cancer with combination therapy

Dr Leena Gandhi - NYU Langone Medical Center, New York, USA
Doubled survival in metastatic lung cancer with combination therapy ( Dr Leena Gandhi - NYU Langone Medical Center, New York, USA )
25 Apr 2018

Combined immuno-chemotherapy improves survival and responses in metastatic lung cancer

Dr Leena Gandhi - NYU Langone Medical Center, New York, USA
Combined immuno-chemotherapy improves survival and responses in metastatic lung cancer ( Dr Leena Gandhi - NYU Langone Medical Center, New York, USA )
25 Apr 2018

Results from CheckMate-227 : Immune combination reaches PFS endpoint

Dr Matthew Hellmann - Memorial Sloan Kettering Cancer Center, New York, USA
Results from CheckMate-227 : Immune combination reaches PFS endpoint ( Dr Matthew Hellmann - Memorial Sloan Kettering Cancer Center, New York, USA )
25 Apr 2018

Editor’s Choice for March 2018

Prof Gordon McVie - Founding Editor, ecancer
Editor’s Choice for March 2018 ( Prof Gordon McVie - Founding Editor, ecancer )
29 Mar 2018

Editor's Choice for February 2018

Prof Gordon McVie - Founding Editor, ecancer
Editor's Choice for February 2018 ( Prof Gordon McVie - Founding Editor, ecancer )
26 Feb 2018

PROSPER RCC study of perioperative nivolumab for renal cell carcinoma - future trial

Dr Lauren Harshman - Dana-Farber Cancer Institute, Boston, USA
PROSPER RCC study of perioperative nivolumab for renal cell carcinoma - future trial ( Dr Lauren Harshman - Dana-Farber Cancer Institute, Boston, USA )
8 Feb 2018

Immunotherapy and targeted treatments in breast cancer reviewed

Dr Hesham El Ghazaly and Prof Leisha Emens
Immunotherapy and targeted treatments in breast cancer reviewed ( Dr Hesham El Ghazaly and Prof Leisha Emens )
29 Jan 2018

The best sequence of anti-HER2 therapy in metastatic breast cancer

Dr Javier Cortes - Vall d’Hebron University Hospital, Barcelona, Spain
The best sequence of anti-HER2 therapy in metastatic breast cancer ( Dr Javier Cortes - Vall d’Hebron University Hospital, Barcelona, Spain )
29 Jan 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation